Androgen receptor and prostate apoptosis response factor-4 target the c-FLIP gene to determine survival and apoptosis in the prostate gland

被引:45
作者
Gao, Shen
Wang, Hua
Lee, Peng
Melamed, Jonathan
Li, Caihong X.
Zhang, Fahao
Wu, Hong
Zhou, Liran
Wang, Zhengxin
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA
[2] NYU, Sch Med, Dept Pathol, New York, NY 10010 USA
关键词
D O I
10.1677/jme.1.01991
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Androgen receptor (AR) is a ligand-activated transcription factor that mediates the action of androgens and is essential for the growth, function, and cell differentiation of the prostate gland. Here, we demonstrated that the prostate apoptosis response factor-4 (par-4) functions as a novel AIR coactivator. Par-4 physically interacted with the DNA-binding domain of AR, enhanced AIR interaction with DNA, and increased AR-dependent transcription. Par-4 enhanced the c-FLIP promoter activity and was recruited on to the c-FLIP gene in the presence of androgens, and the dominant-negative par-4 decreased c-FLIP expression. These results suggest that, in addition to its proapoptortic function, par-4 acts as a novel transcription cofactor for AIR to target c-FLIP gene expression. In addition, we demonstrated that loss of c-FLIP expression was essential for castration-induced apoptosis in the prostate gland and that enhanced c-FLIP expression was associated with prostate cancer progression to the androgen-resistant stage. Our data shed light on a transcription-mediated mechanism for the effects of the AIR pathway on cell survival and apoptosis.
引用
收藏
页码:463 / 483
页数:21
相关论文
共 61 条
  • [1] Role of sex hormones in development of pituitary adenoma
    Babichev, VN
    Marova, EI
    Kuznetsova, TA
    Adamskaya, EI
    Shishkina, IV
    Kasumova, SY
    [J]. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2001, 131 (04) : 309 - 311
  • [2] Androgen receptors in prostate cancer
    Bentel, JM
    Tilley, WD
    [J]. JOURNAL OF ENDOCRINOLOGY, 1996, 151 (01) : 1 - 11
  • [3] Boehrer S, 2002, CANCER RES, V62, P1768
  • [4] Mechanisms of androgen receptor activation and function
    Brinkmann, AO
    Blok, LJ
    de Ruiter, PE
    Doesburg, P
    Steketee, K
    Berrevoets, CA
    Trapman, J
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1999, 69 (1-6) : 307 - 313
  • [5] Chakraborty M, 2001, CANCER RES, V61, P7255
  • [6] c-FLIPL is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis
    Chang, DW
    Xing, Z
    Pan, Y
    Algeciras-Schimnich, A
    Barnhart, BC
    Yaish-Ohad, S
    Peter, ME
    Yang, XL
    [J]. EMBO JOURNAL, 2002, 21 (14) : 3704 - 3714
  • [7] Par-4 transcriptionally regulates bcl-2 through a WT1-binding site on the bcl-2 promoter
    Cheema, SK
    Mishra, SK
    Rangnekar, VM
    Tari, AM
    Kumar, R
    Lopez-Berestein, G
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (22) : 19995 - 20005
  • [8] The androgen-specific probasin response element 2 interacts differentially with androgen and glucocorticoid receptors
    Claessens, F
    Alen, P
    Devos, A
    Peeters, B
    Verhoeven, G
    Rombauts, W
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (32) : 19013 - 19016
  • [9] Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter
    Cleutjens, KBJM
    vanEekelen, CCEM
    vanderKorput, HAGM
    Brinkmann, AO
    Trapman, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (11) : 6379 - 6388
  • [10] Androgen-mediated resistance to apoptosis
    Coffey, RNT
    Watson, RWG
    O'Neill, AJ
    Mc Eleny, K
    Fitzpatrick, JM
    [J]. PROSTATE, 2002, 53 (04) : 300 - 309